Interpretive criteria for testing susceptibility of staphylococci to mupirocin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1137-1139

  Finlay, Jane E ^a   Miller, Linda A ^a   Poupard, James A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; IMPETIGO; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031001952     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1137     Document Type: Article

References (11)

1. Barry, A. L., M. A. Pfaller, and P. C. Fuchs. 1993. Ramoplanin susceptibility testing criteria. J. Clin. Microbiol. 31:1932-1935.
2. Doebbeling, B. N., D. L. Breneman, H. C. Neu, R. Aly, B. G. Yangco, H. P. Holley, R. J. Marsh, M. A. Pfaller, J. E. McGowan, B. E. Scully, D. R. Reagan, and R. P. Wenzel. 1993. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin. Infect. Dis. 17:466-474.
3. Fuchs, P. C., R. N. Jones, and A. L. Barry. 1990. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J. Clin Microbiol. 28:608-609.
4. Hudson, I. R. B. 1994. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J. Hosp. Infect. 27:81-98.
5. Metzler, C. M., and R. M. DeHaan. 1974. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J. Infect. Dis. 130:588-594.
6. Naguib, M. H., M. T. Naguib, and D. J. Flournoy. 1993. Mupirocin resistance in methicillin-resistant Staphylococcus aureus from a veterans hospital. Chemotherapy (Basel) 39:400-404.
7. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. National Committee for Clinical Laboratory Standards. 1994. Development of in vitro susceptibility testing criteria and quality control parameters, vol. 14, no. 9. Approved guideline M23-T2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Poupard, J. A. 1995. Update on mupirocin resistance. J. Chemother. 7(Suppl. 3):71-74.
11. Sutherland, R., R. J. Boon, K. E. Griffin, P. J. Masters, B. Slocombe, and A. R. White. 1985. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother. 27:495-498.